Towards a more functional concept of causality in cancer research.
暂无分享,去创建一个
[1] Hong Zhong,et al. Novel Blood Biomarkers of Human Urinary Bladder Cancer , 2006, Clinical Cancer Research.
[2] J. Chen,et al. Global Gene Expression Profiling in Whole-Blood Samples from Individuals Exposed to Metal Fumes , 2004, Environmental health perspectives.
[3] Paolo Vineis,et al. The impact of new research technologies on our understanding of environmental causes of disease: the concept of clinical vulnerability , 2009, Environmental health : a global access science source.
[4] H. Stefánsson,et al. Genetics of gene expression and its effect on disease , 2008, Nature.
[5] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[6] William C Hahn,et al. Functional genetics and experimental models of human cancer. , 2004, Trends in molecular medicine.
[7] N. Day,et al. Multistage models and primary prevention of cancer. , 1980, Journal of the National Cancer Institute.
[8] Bruce Potter. Necessary but Not Sufficient , 2010, IEEE Secur. Priv..
[9] D. Freedman,et al. Multistage models for carcinogenesis. , 1989, Environmental health perspectives.
[10] Sally A. Amundson,et al. Identification of Potential mRNA Biomarkers in Peripheral Blood Lymphocytes for Human Exposure to Ionizing Radiation , 2000, Radiation research.
[11] D. Altshuler,et al. Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women. , 2007, Cancer research.
[12] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[13] Jun Ma,et al. The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. , 2006, The Journal of laboratory and clinical medicine.
[14] W. Ollier,et al. EBV Immortalization of human B lymphocytes separated from small volumes of cryo-preserved whole blood. , 2008, International journal of epidemiology.
[15] J. V. Moran,et al. Initial sequencing and analysis of the human genome. , 2001, Nature.
[16] N. Rothman,et al. Discovery of Novel Biomarkers by Microarray Analysis of Peripheral Blood Mononuclear Cell Gene Expression in Benzene-Exposed Workers , 2005, Environmental health perspectives.
[17] M. Stratton,et al. The cancer genome , 2009, Nature.
[18] G. Colditz,et al. What can be learnt from models of incidence rates? , 2006, Breast Cancer Research.
[19] D. Mccormick. Sequence the Human Genome , 1986, Bio/Technology.
[20] Denis Noble,et al. Genes and causation , 2008, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.
[21] Siobhan M. Dolan,et al. Assessment of cumulative evidence on genetic associations: interim guidelines. , 2008, International journal of epidemiology.
[22] O. Pereira-smith,et al. The minimal set of genetic alterations required for conversion of primary human fibroblasts to cancer cells in the subrenal capsule assay. , 2005, Neoplasia.
[23] A Morabia,et al. On the origin of Hill's causal criteria. , 1991, Epidemiology.
[24] Gregory Nuel,et al. Deciphering Normal Blood Gene Expression Variation—The NOWAC Postgenome Study , 2010, PLoS genetics.
[25] D. Coppola,et al. Microarray-based identification and RT-PCR test screening for epithelial-specific mRNAs in peripheral blood of patients with colon cancer , 2006, BMC Cancer.
[26] Graham A. Colditz,et al. Merging and emerging cohorts: Not worth the wait , 2007, Nature.
[27] Sandra B. Munro,et al. Detection of Cancer with Serum miRNAs on an Oligonucleotide Microarray , 2009, PloS one.
[28] M. Cotreau,et al. Molecular classification of Crohn's disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cells. , 2006, The Journal of molecular diagnostics : JMD.
[29] T. Peakman,et al. Levels of 5' RNA tags in plasma and buffy coat from EDTA blood increase with time. , 2008, International journal of epidemiology.
[30] Mark S. Clements,et al. Multistage Carcinogenesis and Lung Cancer Mortality in Three Cohorts , 2005, Cancer Epidemiology Biomarkers & Prevention.
[31] John D Potter,et al. Epidemiology, cancer genetics and microarrays: making correct inferences, using appropriate designs. , 2003, Trends in genetics : TIG.
[32] M. Fitó,et al. Time course of changes in the expression of insulin sensitivity-related genes after an acute load of virgin olive oil. , 2009, Omics : a journal of integrative biology.
[33] O. Opitz,et al. In Vitro Transformation Models: Modeling Human Cancer , 2006, Cell cycle.
[34] David Elashoff,et al. Serum circulating human mRNA profiling and its utility for oral cancer detection. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] A. Børresen-Dale,et al. Gene expression profiling of peripheral blood cells for early detection of breast cancer , 2010, Breast Cancer Research.
[36] M. Kumle,et al. Cohort profile: The Norwegian Women and Cancer Study--NOWAC--Kvinner og kreft. , 2008, International journal of epidemiology.
[37] M. Jucker,et al. Koch’s postulates and infectious proteins , 2006, Acta Neuropathologica.
[38] Judy H. Cho,et al. Finding the missing heritability of complex diseases , 2009, Nature.
[39] G. Klein. Toward a genetics of cancer resistance , 2009, Proceedings of the National Academy of Sciences.
[40] O. Kallioniemi,et al. Genetic changes in intraductal breast cancer detected by comparative genomic hybridization. , 1997, The American journal of pathology.
[41] Martin A. Nowak,et al. Genetic Progression and the Waiting Time to Cancer , 2007, PLoS Comput. Biol..
[42] Timothy B. Stockwell,et al. The Sequence of the Human Genome , 2001, Science.
[43] K. Marshall,et al. Novel Blood-Based, Five-Gene Biomarker Set for the Detection of Colorectal Cancer , 2008, Clinical Cancer Research.
[44] Lawrence W Green,et al. Public health asks of systems science: to advance our evidence-based practice, can you help us get more practice-based evidence? , 2006, American journal of public health.
[45] C. Davis,et al. Evidence for dietary regulation of microRNA expression in cancer cells. , 2008, Nutrition reviews.
[46] P. Rothberg,et al. Oncogenes and cancer. , 1983, Cancer investigation.
[47] D. Thelle. STROBE and STREGA: instruments for improving transparency and quality of reporting scientific results , 2008, European Journal of Epidemiology.
[48] Y. Lazebnik. Can a biologist fix a radio? — or, what I learned while studying apoptosis , 2004, Biochemistry (Moscow).
[49] S. Hanash,et al. Mining the plasma proteome for cancer biomarkers , 2008, Nature.
[50] C. Liew,et al. The peripheral-blood transcriptome: new insights into disease and risk assessment. , 2007, Trends in molecular medicine.
[51] Don P. Buesching,et al. Necessary but not sufficient , 1994, Journal of General Internal Medicine.
[52] T. Sellers,et al. Epidemiology — identifying the causes and preventability of cancer? , 2006, Nature Reviews Cancer.
[53] S. Teichmann,et al. A HaemAtlas: characterizing gene expression in differentiated human blood cells , 2008, Blood.
[54] Paolo Vineis,et al. Molecular Epidemiology and Biomarkers in Etiologic Cancer Research: The New in Light of the Old , 2007, Cancer Epidemiology Biomarkers & Prevention.
[55] A. Børresen-Dale,et al. Gene expression analyses in breast cancer epidemiology: the Norwegian Women and Cancer postgenome cohort study , 2008, Breast Cancer Research.
[56] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[57] A. B. Hill. The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.
[58] Paolo Vineis,et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 , 2008, Nature.
[59] M. Carbone,et al. Modern Criteria to Establish Human Cancer Etiology , 2004, Cancer Research.
[60] S. Friend,et al. Signatures of environmental exposures using peripheral leukocyte gene expression: tobacco smoke. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[61] Pagona Lagiou,et al. Causality in cancer epidemiology , 2005, European Journal of Epidemiology.
[62] Rafael Meza,et al. Analysis of lung cancer incidence in the nurses’ health and the health professionals’ follow-up studies using a multistage carcinogenesis model , 2008, Cancer Causes & Control.
[63] Ryoiti Kiyama,et al. Using a customized DNA microarray for expression profiling of the estrogen-responsive genes to evaluate estrogen activity among natural estrogens and industrial chemicals. , 2004, Environmental health perspectives.
[64] A. Green,et al. Microarrays and Epidemiology: Not the Beginning of the End but the End of the Beginning… , 2007, Cancer Epidemiology Biomarkers & Prevention.
[65] A. Børresen-Dale,et al. Gene expression profiling of whole-blood samples from women exposed to hormone replacement therapy , 2006, Molecular Cancer Therapeutics.
[66] E Gabrielson,et al. Genetic divergence in the clonal evolution of breast cancer. , 1996, Cancer research.
[67] J. Potter. Epidemiology informing clinical practice: from bills of mortality to population laboratories , 2005, Nature Clinical Practice Oncology.
[68] Eiliv Lund,et al. Systems Epidemiology in Cancer , 2008, Cancer Epidemiology Biomarkers & Prevention.
[69] I. Tomlinson,et al. What can we learn from the population incidence of cancer? Armitage and Doll revisited. , 2007, The Lancet. Oncology.